Johal KJ, Chichester KL, Oliver ET, Devine KC, et al. The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes. J Allergy Clin Immunol 2021;147:2271-2280.
PMID: 33713769